Ryohei Yamamoto
Direttore/Membro del Consiglio presso Titan, Inc. (Japan)
Posizioni attive di Ryohei Yamamoto
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/05/2013 | - |
Storia della carriera di Ryohei Yamamoto
Precedenti posizioni note di Ryohei Yamamoto
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TELLA, INC. | Direttore Amministrativo | 21/03/2011 | 13/06/2012 |
| Direttore/Membro del Consiglio | 01/02/2010 | 24/03/2015 | |
| Contatto Relazioni con gli Investitori | 13/06/2012 | 01/03/2013 | |
| Public Communications Contact | 13/06/2012 | 01/03/2013 | |
| Corporate Officer/Principal | 21/03/2011 | 21/03/2011 | |
Tella Pharma, Inc.
 Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/01/2014 | - |
Statistiche
Distribuzione geografica
| Giappone | 4 |
Posizioni
| Director/Board Member | 3 |
| Chief Administrative Officer | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Technology | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
Tella Pharma, Inc.
Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Health Technology |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Ryohei Yamamoto
- Esperienza
